
PTC offentliggjorde i dag lovende 12-måneders resultater fra deres fase 2 PIVOT-HD-studie med oral PTC518
At Month 12, mutant Huntingtin (mHTT) in the blood was lowered by 22% and 43% respectively for 5mg and 10mg doses. A similar result was seen in cerebrospinal fluid, where